Morgan Stanley slaps eye-popping price target on Nvidia stock

Nvidia is experiencing surging demand for its Blackwell GPUs, which offer significant performance improvements and are projected to represent 80% of its high-end GPU shipments this year, solidifying its AI ecosystem dominance. The company has also secured approval to resume H20 chip exports to China, evidenced by a massive 300,000-unit order with TSMC, despite ongoing regulatory scrutiny. Analysts at Morgan Stanley have consequently raised Nvidia's 2026 valuation multiple and set a $200 price target, citing robust demand from hyperscalers and enterprises, with anticipated improvements in production and logistics expected to unlock substantial earnings growth in the latter half of the year.

Analysis

Nvidia is experiencing a significant demand surge for its new Blackwell architecture, which is projected by TrendForce to constitute up to 80% of the company's high-end GPU shipments this year. This demand is underpinned by substantial performance gains, with Nvidia claiming a 40x improvement in AI training and inference over the prior Hopper generation and even mid-tier B200 systems demonstrating 57% faster training speeds than the H100. The commercial traction is immediate, as Blackwell sales are already reported to be outpacing the peak of the Hopper cycle, reinforcing Nvidia's dominance in the AI hardware ecosystem. A major strategic development is the resumption of H20 chip exports to China, substantiated by a 300,000-unit order placed with TSMC, signaling strong, pent-up demand despite potential regulatory friction from both Chinese cybersecurity probes and U.S. national security reviews. Reflecting these catalysts, Morgan Stanley has raised its 2026 valuation multiple for Nvidia from 28x to 33x earnings, establishing a $200 price target on a $6.02 mid-year EPS estimate, and anticipates current supply constraints will ease in the second half of the year, unlocking significant earnings growth.

Key Decisions for Investors

• Investors should recognize the powerful dual catalysts of the Blackwell product cycle and the reopening of the China market for H20 chips, which underpin the upgraded valuation and price target from Morgan Stanley.
• It is critical to monitor the geopolitical and regulatory risks associated with H20 chip sales to China, as any formal restrictions or a prolonged cybersecurity probe could temper the upside from this specific revenue stream.
• Execution in the second half of the year is a key variable to watch, as the ability to resolve supply chain bottlenecks is essential to realizing the 'convex earnings leverage' and step-function jump in throughput projected by analysts.